SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001247741-07-000003
Filing Date
2007-05-04
Accepted
2007-05-04 17:17:18
Documents
3
Period of Report
2007-05-04
Items
Item 1.02: Termination of a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CARDINAL AGREEMENT AND JOHN SHARP OFFER LETTER ligand8k050407.txt 8-K 6677
2 JOHN SHARP OFFER LETTER ex10-1.txt EX-10 4786
3 PRESS RELEASE ANNOUNCING JOHN SHARPS APPOINTMENT ex99-1.txt EX-99 4309
  Complete submission text file 0001247741-07-000003.txt   17422
Mailing Address 10275 SCIENCE CENTER DRIVE SAN DIEGO CA 92121-1117
Business Address 10275 SCIENCE CENTER DRIVE SAN DIEGO CA 92121-1117 8585507500
LIGAND PHARMACEUTICALS INC (Filer) CIK: 0000886163 (see all company filings)

IRS No.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33093 | Film No.: 07821481
SIC: 2834 Pharmaceutical Preparations